An Epidemiologic Study of prn/stat Medication Use in a State Psychiatric Hospital

REFERENCES

• McLaren S, Browne FWA, Taylor PJ: Study of psychotropic medication given "as requested" in a regional secure unit. Br J Psychiatry 1990; 156:732–735
   PubMed Web of Science ®Google Scholar
• Walker R: PRN psychotropic use on a psychiatric unit. Psy-chiat Q 1991; 62:1–8
   PubMedGoogle Scholar
• Ayd FJ Jr: Problems with orders for medication as needed. Am 3 Psychiatry 1985; 142:939–942
   Google Scholar
• Cole JO: Medication and seclusion and restraint. McLean Hosp J 1985; X:37–53
   Google Scholar
• Fisher WA: Restraint and seclusion: A review of the litera-ture. Am J Psychiatry 1994; 151:1584–1591
   PubMed Web of Science ®Google Scholar
• Tardiff K (Chairman): Report of the American Psychiatric As-sociation Task Force on the Psychiatric Uses of Seclusion and Restraint. Jan 1984
   Google Scholar
• Okin RL: Variation among state hospitals in use of seclusion and restraint. Hosp Community Psychiatry 1985; 36:648–657
   PubMedGoogle Scholar
• Carpenter MD, Hannon VR, McCleery G, Wanderling JA: Variations in seclusion and restraint practice by hospital lo-cation. Hosp Community Psychiatry 1988; 39:418–423
   PubMedGoogle Scholar
• Carpenter MD, Hannon VR, McCleery G, Wanderling JA: Ethnic differences in seclusion and restraint. J Nerv Ment Dis 1988; 176:726–731
   PubMedGoogle Scholar
• Betemps EJ, Somoza E, Buncher CR: Hospital charac-teristics, diagnoses, and staff reasons associated with use of seclusion and restraint. Hosp Community Psychiatry 1993; 44:367–371
   PubMedGoogle Scholar
• Bornstein PE: The use of restraints on a general psychiatric unit. J Clin Psychiatry 1985; 46:175–178
   PubMed Web of Science ®Google Scholar
• Lion JR: Conceptual issues in the use of drugs for the treat-ment of aggression in man. J Nerv Men Dis 1975; 160:76–81
   PubMed Web of Science ®Google Scholar
• Torrey EF: Violent behavior by individuals with serious men-tal illness. Hosp Community Psychiatry 1994; 45:653–662
   PubMedGoogle Scholar
• Yesavage JA, Holman CA, Cohn R, Lombrozo L: Correlation of initial thiothixene serum levels and clinical response. Arch Gen Psychiatry 1983; 40:301–304
   Google Scholar
• Harris PQ, Friedman MJ, Cohen BM, Cooper TB: Fluphenazine blood levels and clinical response. Biol Psychia-try 1982; 17:1123–1130
   PubMed Web of Science ®Google Scholar
• Brown WA, Laughen T: Low serum prolactin and early re-lapse following neuroleptic withdrawal. Am J Psychiatry 1981; 138:237–239
   PubMed Web of Science ®Google Scholar
• Jayaram G, Coyle J, Tune L: Relapse in chronic schizophren-ics treated with fluphenazine decanoate is associated with low serum neuroleptic levels. J Clin Psychiatry 1986; 47:247–248
   Google Scholar
• Van Putten 1 Marder SR, Mintz, Poland RE: Haloperidol plasma levels and clinical response: A therapeutic window re-lationship. Am J Psychiatry 1992; 149:500–505
   PubMedGoogle Scholar
• Yesavage JA: Inpatient violence and the schizophrenic pa-tient: An inverse correlation between danger-related events and neuroleptic levels. Biol Psychiatry 1982; 17:331–333
   Google Scholar
• Silver JA, Yudofsky SC: Documentation of aggression in the assessment of the violent patient. Psychiat Ann 1987; 17:375–384
   Web of Science ®Google Scholar
• Simpson GM, Cooper TB, Bark N, Sud I, Lee JH: Effect of antiparkinsonian medication on plasma levels of chlorpro-mazine. Arch Gen Psychiatry 1980; 37: 205–208
   PubMed Web of Science ®Google Scholar
• Craig TJ, Mehta RM: Clinician-computer interaction: Auto-mated review of psychotropic drugs five years later. Am J Psy-chiatry 1984; 141:267–270
   Google Scholar
• Lawson GM: Monitoring of serum haloperidol. Mayo Clin Proc 1994; 69:189–190
   Google Scholar
• Bernado M, Palao DJ, Arauxo A, Brunet M, Marquez M: Monitoring plasma level of haloperidol in schizophrenia. Hosp Community Psychiatry 1993; 44:115–118
   Google Scholar
• Zohar J, Shemesh Z, Belmaker RH: Utility of neuroleptic blood levels in the treatment of acute psychosis. J Clin Psy-chiatry 1986; 47:600–603
   Google Scholar
• Linnoila M, Vuikari M, Vaisanen K, Auvinen J: Effect of an-ticonvulsant on plasma haloperidol and thioridazine levels. Am J Psychiatry 1980; 137:819–821
   PubMed Web of Science ®Google Scholar
• Pi EH, Simpson GM: The treatment of refractory schizophre-nia: Pharmacotherapy and clinical implication of blood level measurement of neuroleptics. Int Pharmacopsychiat 1981; 16:154–161
   Google Scholar
• Wolkowitz OM, Pickar D: Benzodiazepines in the treatment of schizophrenia: A review and reappraisal. Am J Psychiatry 1991; 148:714–726
   PubMed Web of Science ®Google Scholar
• Evans R, DiSapio W: Nonpharmacologic factors in the ad-ministration of pm psychotropic medication on an adolescent unit. Am J Psychiatry 1980; 137:123–124
   PubMedGoogle Scholar
• Vitiello B, Ricciuti AJ, Behar D: PRN medication in child state hospital patients. J Clin Psychiatry 1987; 48:351–354
   PubMed Web of Science ®Google Scholar
• Cooper SJ, Browne FWA, McClean KJ: Aggressive behavior in a psychiatric observation ward. Acta Psychiatr Scand 1983; 68:386–393
   PubMed Web of Science ®Google Scholar